Menopause Matters Forum
Menopause Discussion => All things menopause => Topic started by: CLKD on November 09, 2017, 07:39:29 PM
-
Did anyone listen to Jeremy Vine today ? He had discussion with Professor Richard Gary who has been part of a Study regarding women with oestrogen sensitive breast disease who had stopped Tamoxifen after the initial 5 year advice. Some in the study had been diagnosed for a 2nd time within 15 years of stopping the anti-oestrogen drug (I think I heard it correctly). It is now thought that ladies should have either Tamoxifen or 1 of the other options for at least 10 years post surgery.
During the end of the interview which I plan to listen to again, he did mention that in general there is so little oestrogen in HRT that it shouldn't be discounted as a treatment for women with unbearable meno symptoms, even post surgery.
Do listen. As someone who suffered severe side-effects from Tamoxifen that it almost killed me, I do wish I'd been part of the Study ::) and there was no mention of womb cancer from this particular drug. Which a friend died of :'(
I found it interesting and for once, Jeremy actually listened and rarely butted in!
-
Thanks CLKD, that is interesting. I believe Bazedoxifene is used in the US for the same purpose as Tamoxifen and seems to be having some success. Perhaps Duavive (oestrogen and bazedoxifene) would be a good and less risky HRT option for women who have had BC in the past?
-
They were names that I didn't recognise. Said so quickly ::) which is why I want to listen again.
I had my Surgery in 1996 (?) and stopped the Tamoxifen due to dreadful side-effects. Fortunately so far there is no sign of recurrence. It is obvious too that some cancers are not 'the same' as the initial disease. Mine was found on palpation.